Autolus Therapeutics PLC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Autolus Therapeutics plc reports a Form 4 filing detailing Director William D. Young's acquisition of restricted stock units and share options.
NASDAQ
Ryan Richardson, a Director at Autolus Therapeutics plc, has acquired restricted stock units and share options.
NASDAQ
Autolus Therapeutics Director Elisabeth Leiderman acquired restricted stock units and share options, signaling confidence in the company's future.
NASDAQ
Autolus Therapeutics plc reports a Form 4 filing detailing Robert Iannone's acquisition of restricted stock units and share options.
NASDAQ
Autolus Therapeutics Director Cynthia M. Butitta acquired restricted stock units and share options, increasing her beneficial ownership.
NASDAQ
Autolus Therapeutics plc reports a Form 4 filing detailing share transactions by Director Linda Bain, including the acquisition of restricted stock units and share options.
NASDAQ
Robert Azelby, a Director at Autolus Therapeutics plc, has acquired restricted stock units and share options.
NASDAQ
Autolus Therapeutics Director Michael W. Bonney acquired restricted stock units and stock options, signaling continued investment in the company.